GMDA logo

Gamida Cell (GMDA) Company Overview

Profile

Full Name:

Gamida Cell Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

October 26, 2018

Indexes:

Not included

Description:

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 15, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 29, 24 JMP Securities
Market Perform
Dec 5, 23 Needham
Buy
Nov 15, 23 Piper Sandler
Overweight
Nov 15, 23 HC Wainwright & Co.
Buy
Sep 28, 23 JMP Securities
Market Outperform
Aug 16, 23 HC Wainwright & Co.
Buy
Aug 15, 23 Needham
Buy
Jun 30, 23 Needham
Buy
May 24, 23 JMP Securities
Market Outperform
May 22, 23 HC Wainwright & Co.
Buy

Screeners with GMDA included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Gamida Cell?
  • Does Gamida Cell pay dividends?
  • What sector is Gamida Cell in?
  • What industry is Gamida Cell in?
  • What country is Gamida Cell based in?
  • When did Gamida Cell go public?
  • Is Gamida Cell in the S&P 500?
  • Is Gamida Cell in the NASDAQ 100?
  • Is Gamida Cell in the Dow Jones?
  • When was Gamida Cell's last earnings report?
  • When does Gamida Cell report earnings?
  • Should I buy Gamida Cell stock now?

What is the ticker symbol for Gamida Cell?

The ticker symbol for Gamida Cell is NASDAQ:GMDA

Does Gamida Cell pay dividends?

No, Gamida Cell does not pay dividends

What sector is Gamida Cell in?

Gamida Cell is in the Healthcare sector

What industry is Gamida Cell in?

Gamida Cell is in the Biotechnology industry

What country is Gamida Cell based in?

Gamida Cell is headquartered in Israel

When did Gamida Cell go public?

Gamida Cell's initial public offering (IPO) was on October 26, 2018

Is Gamida Cell in the S&P 500?

No, Gamida Cell is not included in the S&P 500 index

Is Gamida Cell in the NASDAQ 100?

No, Gamida Cell is not included in the NASDAQ 100 index

Is Gamida Cell in the Dow Jones?

No, Gamida Cell is not included in the Dow Jones index

When was Gamida Cell's last earnings report?

Gamida Cell's most recent earnings report was on May 15, 2024

When does Gamida Cell report earnings?

The date for Gamida Cell's next earnings report has not been announced yet

Should I buy Gamida Cell stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions